Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia – The PREDICT study

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 12, 2017, Pages 3671-3682

  Hoffmann, Sarah ^a   Harms, Hendrik ^b   Ulm, Lena ^a   Nabavi, Darius G ^c   Mackert, Bruno Marcel ^d   Schmehl, Ingo ^e   Jungehulsing, Gerhard J ^a,f   Montaner, Joan ^g   Bustamante, Alejandro ^g   Hermans, Marcella ^c   Hamilton, Frank ^d   Göhler, Jos ^a   Malzahn, Uwe ^h,i   Malsch, Carolin ^h,i   Heuschmann, Peter U ^h,i   Meisel, Christian ^a   Meisel, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b St Josefs Krankenhaus Potsdam Sanssouci   (Germany)

^c VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^d Vivantes Auguste Viktoria Klinikum   (Germany)

^e UNFALLKRANKENHAUS BERLIN   (Germany)

^f Judisches Krankenhaus Berlin   (Germany)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h UNIVERSITY OF WÜRZBURG   (Germany)

ⁱ UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Acute stroke; immunology; infection; inflammation; macrophages

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BRAIN ISCHEMIA; CANDIDA; CEREBROVASCULAR ACCIDENT; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE SEVERITY; DYSPHAGIA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HUMAN; IMMUNE DEFICIENCY; IMMUNOASSAY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY; CLINICAL TRIAL; COMPLICATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MACROPHAGE; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS;

AGED; AGED, 80 AND OVER; DEGLUTITION DISORDERS; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-6; MACROPHAGES; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 85036648449     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16671964     Document Type: Article

References (40)

1. Katzan IL, Cebul RD, Husak SH, The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003; 60: 620–625.
2. Koennecke HC, Belz W, Berfelde D, Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology 2011; 77: 965–972.
3. Martino R, Foley N, Bhogal S, Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005; 36: 2756–2763.
4. Perry L, Love CP. Screening for dysphagia and aspiration in acute stroke: a systematic review. Dysphagia 2001; 16: 7–18.
5. Dziewas R, Ritter M, Schilling M, Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry 2004; 75: 852–856.
6. Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007; 38: 1097–1103.
7. Meisel C, Schwab JM, Prass K, Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6: 775–786.
8. Dirnagl U, Klehmet J, Braun JS, Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007; 38(2 Suppl): 770–773.
9. Klehmet J, Harms H, Richter M, Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009; 158: 1184–1193.
10. Prass K, Meisel C, Hoflich C, Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198: 725–736.
11. Chamorro A, Meisel A, Planas AM, The immunology of acute stroke. Nat Rev Neurol 2012; 8: 401–410.
12. Urra X, Cervera A, Obach V, Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke 2009; 40: 1262–1268.
13. Zhang DP, Yan FL, Xu HQ, A decrease of human leucocyte antigen-DR expression on monocytes in peripheral blood predicts stroke-associated infection in critically-ill patients with acute stroke. Eur J Neurol 2009; 16: 498–505.
14. Wartenberg KE, Stoll A, Funk A, Infection after acute ischemic stroke: risk factors, biomarkers, and outcome. Stroke Res Treat 2011; 2011: 830614.
15. Worthmann H, Tryc AB, Dirks M, Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection. J Neuroinflamm 2015; 12: 13.
16. Adams HP, Jr Bendixen BH, Kappelle LJ, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.
17. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Contr 2008; 36: 309–332.
18. Bustamante A, Sobrino T, Giralt D, Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis. J Neuroimmunol 2014; 274: 215–224.
19. Harms H, Prass K, Meisel C, Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PloS One 2008; 3: e2158.
20. Wolk K, Docke WD, von Baehr V, Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000; 96: 218–223.
21. Kwan J, Horsfield G, Bryant T, IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke. Exp Gerontol 2013; 48: 960–965.
22. Villar J, Maca-Meyer N, Perez-Mendez L, Bench-to-bedside review: understanding genetic predisposition to sepsis. Crit Care 2004; 8: 180–189.
23. Hannawi Y, Hannawi B, Rao CP, Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis 2013; 35: 430–443.
24. Hassan A, Khealani BA, Shafqat S, Stroke-associated pneumonia: microbiological data and outcome. Singapore Med J 2006; 47: 204–207.
25. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115: 928–935.
26. Kalra L, Irshad S, Hodsoll J, Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet 2015; 386: 1835–1844.
27. Westendorp WF, Vermeij JD, Zock E, The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet 2015; 385: 1519–1526.
28. Engel O, Akyuz L, da Costa Goncalves AC, Cholinergic pathway suppresses pulmonary innate immunity facilitating pneumonia after stroke. Stroke 2015; 46: 3232–3240.
29. Houlden A, Goldrick M, Brough D, Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun 2016; 57: 10–20.
30. Winek K, Engel O, Koduah P, Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke. Stroke 2016; 47: 1354–1363.
31. Kishore AK, Vail A, Chamorro A, How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis. Stroke 2015; 46: 1202–1209.
32. Smith CJ, Kishore AK, Vail A, Diagnosis of stroke-associated pneumonia: Recommendations from the pneumonia in stroke consensus group. Stroke 2015; 46(8): 2335–2340.
33. Harms H, Hoffmann S, Malzahn U, Decision-making in the diagnosis and treatment of stroke-associated pneumonia. J Neurol Neurosurg Psychiatry 2012; 83: 1225–1230.
34. Gonzalez-Fernandez M, Kuhlemeier KV, Palmer JB. Racial disparities in the development of dysphagia after stroke: analysis of the California (MIRCal) and New York (SPARCS) inpatient databases. Archiv Phys Med Rehab 2008; 89: 1358–1365.
35. Walter U, Knoblich R, Steinhagen V, Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol 2007; 254: 1323–1329.
36. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457–507
37. Leder SB, Espinosa JF. Aspiration risk after acute stroke: comparison of clinical examination and fiberoptic endoscopic evaluation of swallowing. Dysphagia 2002; 17: 214–218.
38. Masrur S, Smith EE, Saver JL, Dysphagia screening and hospital-acquired pneumonia in patients with acute ischemic stroke: findings from Get with the Guidelines–Stroke. J Stroke Cerebrovasc Dis 2013; 22: e301–e309.
39. Hinchey JA, Shephard T, Furie K, Formal dysphagia screening protocols prevent pneumonia. Stroke 2005; 36: 1972–1976.
40. Meisel A, Smith CJ. Prevention of stroke-associated pneumonia: where next? Lancet 2015; 386(10006): 1802–1804.